These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2375145)

  • 1. Boards in clinical pharmacology: portent for pharmacy and pharmacotherapy.
    McLeod DC
    DICP; 1990; 24(7-8):779-80. PubMed ID: 2375145
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for boards in clinical pharmacology.
    DiPalma JR
    JAMA; 1980 May; 243(19):1918-20. PubMed ID: 7365973
    [No Abstract]   [Full Text] [Related]  

  • 3. Board certification in clinical pharmacology: bane or boon?
    McLeod DC
    Drug Intell Clin Pharm; 1979 Sep; 13(9):524-5. PubMed ID: 10244128
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy specialty certification examination. IV. 1992 results and process modifications, including recertification. The 1992 Specialty Council on Pharmacotherapy, Board of Pharmaceutical Specialties.
    Zarowitz BJ; Vlasses PH; Dukes GE; Gal P; Miller WA; Porter WC; Rush DR; Schneider P; Talbert RL
    Pharmacotherapy; 1993; 13(3):262-6. PubMed ID: 8321740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of clinical pharmacology services provided by board certified clinical pharmacologists in Japan.
    Fujimura A; Yasuhara H; Nakano S;
    Br J Clin Pharmacol; 2008 Mar; 65(3):442-3. PubMed ID: 17953717
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits of becoming a board-certified pharmacotherapy specialist.
    Zarowitz BJ
    Am J Hosp Pharm; 1992 Nov; 49(11):2674, 2679. PubMed ID: 1471624
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on Pharmacotherapy.
    Dukes GE; Gal P; Miller WA; Porter WC; Rush DR; Schneider P; Talbert RL; Vlasses PH; Zarowitz BJ
    Pharmacotherapy; 1992; 12(6):477-83. PubMed ID: 1492013
    [No Abstract]   [Full Text] [Related]  

  • 8. The American Board of Clinical Pharmacology, Inc., and academic clinical pharmacology: is there a down side?
    Brass EP; Feldman RD
    Clin Pharmacol Ther; 1994 Aug; 56(2):122-4; discussion 125-6. PubMed ID: 8062487
    [No Abstract]   [Full Text] [Related]  

  • 9. NRC's approach to nuclear pharmacy education.
    DelMedico J
    Am Pharm; 1981 Oct; NS21(10):48-9. PubMed ID: 7340494
    [No Abstract]   [Full Text] [Related]  

  • 10. Survey and overview: nuclear pharmacy education.
    Schlegel JF; Shaw SM
    Am Pharm; 1981 Oct; NS21(10):38-9. PubMed ID: 7340489
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear pharmacy PhD programs.
    Ice RD; Basmadjian G
    Am Pharm; 1981 Oct; NS21(10):44-5. PubMed ID: 7340492
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy specialty certification examination. V. Further experience and refinement. The 1996 Specialty Council on Pharmacotherapy, Board of Pharmaceutical Specialties.
    Bosso JA; Stringer KA; Hammond RW
    Pharmacotherapy; 1997; 17(2):399-406. PubMed ID: 9085339
    [No Abstract]   [Full Text] [Related]  

  • 13. Summary of petition requesting recognition of pharmacotherapy as a specialty. American College of Clinical Pharmacy.
    Am J Hosp Pharm; 1988 Apr; 45(4):898-904. PubMed ID: 3376971
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on Pharmacotherapy.
    Vlasses PH; Rush DR; Dukes GE; Gal P; Miller WA; Porter WC; Schneider P; Talbert RL; Zarowitz BJ
    Pharmacotherapy; 1992; 12(6):491-4. PubMed ID: 1492015
    [No Abstract]   [Full Text] [Related]  

  • 15. A perspective on the American Board of Clinical Pharmacology, Inc.
    Shepherd AM
    Clin Pharmacol Ther; 1990 Dec; 48(6):611-2. PubMed ID: 2249371
    [No Abstract]   [Full Text] [Related]  

  • 16. The American Society for Clinical Pharmacology and Therapeutics: its role in board certification in clinical pharmacology.
    Carr EA
    Clin Pharmacol Ther; 1990 Feb; 47(2):291-7. PubMed ID: 2406087
    [No Abstract]   [Full Text] [Related]  

  • 17. Background and present status of the American Board of Clinical Pharmacology.
    Hutcheon D
    J Clin Pharmacol; 1979; 19(5-6):253-6. PubMed ID: 469020
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy. Part II. Administering the certification process.
    McLeod DC
    DICP; 1989 Dec; 23(12):1031. PubMed ID: 2603442
    [No Abstract]   [Full Text] [Related]  

  • 19. Added qualifications: a new dimension in pharmacy specialty certification.
    Bertin RJ
    Ann Pharmacother; 1997 Dec; 31(12):1532-4. PubMed ID: 9416395
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigating the potential influence of established multiple-choice test-taking cues on item response in a pharmacotherapy board certification examination preparatory manual: a pilot study.
    Gettig JP
    Pharmacotherapy; 2006 Apr; 26(4):558-62. PubMed ID: 16553516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.